F-group (family)
2004.1.1.52 Herpes_TK
Ligands and drugs
79
Member domains
79
with ligand contacts (≤ 4 Å)
100.0% of members
79
with DrugDomain annotations
100.0% of members
79
with a DrugBank compound
100.0% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 2004.1.1.52 belongs to X-group 2004 P-loop domains-like, which binds 7.5 ligand superclasses per 20 proteins, narrower than 53% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB04485 | THM | Thymidine | 10 |
| DB16833 | ADP | Adenosine disphosphate | 9 |
| DB03280 | T5A | p1-(5'-adenosyl)p5-(5'-thymidyl)pentaphosphate | 5 |
| DB04438 | BVP | Brivudine monophosphate | 4 |
| DB17805 | TMC | North-methanocarbathymidine | 4 |
| DB00249 | ID2 | Idoxuridine | 2 |
| DB00299 | PE2 | Penciclovir | 2 |
| DB00787 | AC2 | Acyclovir | 2 |
| DB01004 | GA2 | Ganciclovir | 2 |
| DB02495 | BPG | 9-(4-hydroxybutyl)-N2-phenylguanine | 2 |
| DB02500 | CCV | 6-(Dihydroxy-Isobutyl)-Thymine | 2 |
| DB02765 | ARP | R-9-(2-hydroxypropyl)adenine | 2 |
| DB02921 | SCT | (South)-Methanocarba-Thymidine | 2 |
| DB03000 | APS | S-9-(2-hydroxypropyl)adenine | 2 |
| DB03312 | BVD | Brivudine | 2 |
| DB03804 | BTD | 5-Bromothienyldeoxyuridine | 2 |
| DB04139 | HPT | 6-Hydroxypropylthymine | 2 |
| DB01643 | TMP | Thymidine monophosphate | 1 |
| DB02324 | 5IU | 5-Iodo-2'-Deoxyuridine-5'-Monophosphate | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| THM | THYMIDINE | 10 |
| ADP | ADENOSINE-5'-DIPHOSPHATE | 9 |
| T5A | P1-(5'-ADENOSYL)P5-(5'-THYMIDYL)PENTAPHOSPHATE | 5 |
| 4TA | P1-(5'-ADENOSYL)P4-(5'-(2'-DEOXY-THYMIDYL))TETRAPHOSPHATE | 4 |
| BVP | (E)-5-(2-BROMOVINYL)-2'-DEOXYURIDINE-5'-MONOPHOSPHATE | 4 |
| TMC | 1-[4-HYDROXY-5-(HYDROXYMETHYL)BICYCLO[3.1.0]HEX-2-YL]-5-METHYLPYRIMIDINE-2,4(1H,3H)-DIONE | 4 |
| AC2 | 9-HYROXYETHOXYMETHYLGUANINE | 2 |
| AHU | 1',5'-ANHYDRO-2',3'-DIDEOXY-2'-(5-IODOURACIL-1-YL)-D-ABABINO-HEXITOL | 2 |
| APS | 9-HYDROXYPROPYLADENINE, S-ISOMER | 2 |
| ARP | 9-HYDROXYPROPYLADENINE, R-ISOMER | 2 |
| BPG | 9-(4-HYDROXYBUTYL)-N2-PHENYLGUANINE | 2 |
| BTD | 5-BROMOTHIENYLDEOXYURIDINE | 2 |
| BVD | 5-BROMOVINYLDEOXYURIDINE | 2 |
| CCV | 6-[3-HYDROXY-2-(HYDROXYMETHYL)PROPYL]-5-METHYL-2,4(1H,3H)-PYRIMIDINEDIONE | 2 |
| EDU | 2'-deoxy-5-ethynyluridine | 2 |
| EDV | 1-(2-deoxy-2-methyl-beta-D-arabinofuranosyl)-5-ethynylpyrimidine-2,4(1H,3H)-dione | 2 |
| F2U | 2'-deoxy-5-ethynyl-2',2'-difluorouridine | 2 |
| FDU | 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-ethynylpyrimidine-2,4(1H,3H)-dione | 2 |
| FSK | 6-[(1Z)-3-fluoro-2-(hydroxymethyl)prop-1-en-1-yl]-1,5-dimethylpyrimidine-2,4(1H,3H)-dione | 2 |
| GA2 | 9-(1,3-DIHYDROXY-PROPOXYMETHANE)GUANINE | 2 |